NHF’s QMS is ISO 9001:2015 Certified

Government of Jamaica

GLAUCOMA PATIENTS ENROLLED WITH NHF NOW HAVE ACCESS TO NEW EYE DROP

GLAUCOMA PATIENTS ENROLLED WITH NHF NOW HAVE ACCESS TO NEW EYE DROP

Over twenty-eight thousand patients enrolled with the National Health Fund for Glaucoma, now have access to a new Active Pharmaceutical Ingredient (API), which is a combination of Brimonidine & Timolol. This new eye drop, under the Combigan label receives a NHF subsidy of $1,038.41 per 5-millilitre vial.

Other additions to the NHF Drug List include a new generic label for Topiramate under the Topaz label, used for the treatment of Epilepsy and Depression. The subsidy for Topaz is $25.71 for each 25milligram tablet.

Over 1,300 prescription items are now on the NHF Drug List and patients and their health providers can review a complete list of subsidized prescriptions on the NHF Drug List on the NHF website (www. NHF.ORG.JM)

National Health Fund © 2024. All Rights Reserved.